| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |